Wednesday, December 26, 2018

The U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc's Elzonris for the treatment of a rare blood disease in adults and children aged two years and above.


from Reuters: Health News https://reut.rs/2RcfIuD

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Most doctors who treat young athletes for concussion know that the injury increases the risk of having a car accident, but barely half counsel their patients against driving, a U.S. study suggests. fro… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Middle-aged adults who lose most of their net worth over a brief period of time are more likely to die prematurely than individuals who hold on to their nest eggs, a U.S. study suggests. from Reuters: … Read More
  • LATEST HEALTH NEWSSEOUL (Reuters) - South Koreans who enjoy a rare flavor of soju, the country's most beloved alcohol, have been discouraged from mixing wasps into their drinks as a tonic after a health warning from the food ministry. fro… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Mothers of babies with heart defects are themselves at higher-than-average risk for being hospitalized with heart disease later in life, researchers say. from Reuters: Health News https://ift.tt/2uKuVs… Read More
  • LATEST HEALTH NEWSOsteopenia is a condition in which bone mineral density is lower than normal from Health https://ift.tt/2uxsPMI … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner